Professor Carl Macrae warns of healthcare AI patient safety gaps
Is this a scandal?
Not yet — early signal: noise 38/100 · state: Emerging · 1 source item across 1 platform · peaked at 40/100 on Jun 17, 2026. — as of , measured by the SCAND.Ai noise pipeline.
Incident ID: SCAND-159699
Cite this incident
"Professor Carl Macrae warns of healthcare AI patient safety gaps." SCAND.Ai incident SCAND-159699, noise 38/100 as of June 17, 2026. https://scand.ai/scandal/macrae-warns-healthcare-ai-safety-gapsWhy It Matters
As AI deployment in clinical settings accelerates, the lack of systemic safety infrastructure risks untraceable patient harm and a subsequent regulatory backlash that could stall beneficial medical AI adoption.
Key Points
- Professor Carl Macrae's paper warns that healthcare systems lack the governance to investigate AI-related patient injuries.
- The research highlights systemic risks arising from the interaction of flawed AI models and human clinical vulnerabilities like automation bias.
- The study recommends establishing a system-wide AI learning infrastructure similar to drug-monitoring pharmacovigilance regimes.
- Failure to build robust safety frameworks could trigger a severe public backlash that delays beneficial clinical AI deployment.
A new study in the Journal of the Royal Society of Medicine warns that global healthcare systems are currently unequipped to detect, investigate, or learn from AI-related patient harm. Written by University of Nottingham professor Carl Macrae and supported by the UK AI Security Institute, the paper argues that clinical AI deployment is rapidly outpacing necessary safety infrastructure. Macrae asserts that when AI systems contribute to clinical injuries or deaths, healthcare providers lack the specialized monitoring and investigative frameworks required to identify the technology's role. The study calls for the immediate establishment of a system-wide AI safety learning infrastructure, comparing the requirement to existing pharmacovigilance regimes used for monitoring controlled substances. Macrae warns that failing to build these governance frameworks could trigger severe public backlash, ultimately delaying the deployment of life-saving medical AI technologies globally.
We are rushing to put AI into hospitals without any real plan for what happens when it makes a mistake. A new paper by Professor Carl Macrae explains that if an AI system contributes to a patient's injury or death today, hospitals don't have the tools or experts to figure out what went wrong. It is not just about bad code; it is about tired doctors trusting AI blindly. Macrae argues we need a safety monitoring system for AI, similar to how we track dangerous drugs, before a major tragedy triggers a massive public backlash.
Sides
Critics
Argues that current healthcare systems are dangerously unprepared to monitor, investigate, and learn from AI-related patient harm.
Defenders
No defenders identified
Neutral
Supported the research examining systemic risks and governance gaps in healthcare AI deployments.
Noise Level
Forecast
Healthcare regulators are likely to face increased pressure to mandate standardized AI incident reporting frameworks. In the near term, look for pilot programs attempting to adapt traditional pharmacovigilance models to clinical AI monitoring.
Based on current signals. Events may develop differently.
Timeline
Research paper on healthcare AI safety gaps published
Professor Carl Macrae publishes a critical paper in the Journal of the Royal Society of Medicine warning of systemic gaps in AI patient safety governance.
Join the Discussion
Discuss this story
Community comments coming in a future update
Be the first to share your perspective. Subscribe to comment.